Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-6054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-50 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10 |
filingDate |
2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a554b778d9f8394c039009bd4abbb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1e93df917d2db8bb0e5327da3c7aff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e12daf16d7459f66440d0c6bde41c5 |
publicationDate |
2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-109661196-A |
titleOfInvention |
Basal titration with adaptive target glucose level |
abstract |
Systems and methods are provided for adjusting the dose of a long-acting insulin drug to a subject. Obtain multiple time-stamped glucose measurements and insulin injection data for the subject. determining a first blood glucose risk measure, wherein the first risk blood glucose risk measure is: i) variability in glucose levels across glucose measurements, (ii) variability in fasting blood glucose levels calculated from glucose measurements, (iii) variability across multiple glucose levels Minimum observed glucose measurement in measurement (iv) rate of change in ISF, or (v) compliance value. A fasting blood glucose target function is calculated based on at least the first blood glucose risk metric to obtain an updated target fasting blood glucose level between the minimum and maximum target fasting blood glucose levels. Long-acting insulin drug doses are adjusted based on updated target fasting blood glucose levels. |
priorityDate |
2016-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |